newsfilter
← Latest News
GlobeNewswire·

Marker Therapeutics Announces $16.1 Million Private Placement

HOUSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of